MapLight Therapeutics (MPLT) Balance Sheet: Assets & Liabilities

MapLight Therapeutics (MPLT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), MapLight Therapeutics reported total assets of $479.51M and total liabilities of $21.14M. Shareholders' equity was $458.37M, up 297.9% from $115.19M a year earlier. Total debt stood at $5.80M against $305.10M in cash and short-term investments, a net cash position of $299.30M. That puts debt-to-equity at 0.01, compared with 0.06 a year earlier.

MapLight Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for MapLight Therapeutics, Inc. (MPLT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	46.73	38.25	79.77	27.67
Short-Term Investments	258.37	70.54	0.00	0.00
Cash & Short-Term Investments	305.10	108.80	79.77	27.67
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	19.57	5.81	3.84	4.37
Total Current Assets	324.67	114.60	83.60	32.03
Non-Current Assets
Property, Plant & Equipment (Net)	6.58	7.56	6.59	7.12
Long-Term Investments	147.99	11.59	1.22	0.23
Other Non-Current Assets	0.27	3.17	0.00	0.00
Total Non-Current Assets	154.84	22.31	7.81	7.36
Total Assets	479.51	136.92	91.41	39.39
Current Liabilities
Accounts Payable	3.29	1.91	0.00	0.00
Short-Term Debt	0.89	0.78	0.50	0.35
Accrued Liabilities	12.05	9.99	6.76	2.79
Deferred Revenue	0.00	3.24	4.20	5.86
Other Current Liabilities	15.34	9.99	10.01	6.39
Total Current Liabilities	16.23	15.92	14.70	12.60
Non-Current Liabilities
Long-Term Debt	4.91	5.80	5.43	5.92
Other Non-Current Liabilities	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	4.91	5.80	5.43	5.92
Total Liabilities	21.14	21.72	20.13	18.52
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00
Retained Earnings	-360.52	-199.37	-121.79	-66.08
Accumulated Other Comprehensive Income	-0.23	0.16	0.00	0.00
Additional Paid-in Capital	819.12	5.58	4.20	3.12
Shares Outstanding	44.02	-	-	-
Total Stockholders' Equity	458.37	115.20	71.28	20.87
Total Liabilities & Equity	479.51	136.92	91.41	39.39

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About MapLight Therapeutics Balance Sheet

How much debt does MapLight Therapeutics have?

MapLight Therapeutics had total debt of $5.80M as of Dec 31, 2025, against $305.10M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $6.58M a year earlier.

What are MapLight Therapeutics's total assets?

MapLight Therapeutics reported total assets of $479.51M as of Dec 31, 2025, up 250.2% from $136.92M a year earlier. Total liabilities were $21.14M.

What is MapLight Therapeutics's shareholders' equity?

MapLight Therapeutics's shareholders' equity was $458.37M as of Dec 31, 2025, or about $10.41 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition